conference that will make the case for Cosentyx (secukinumab) in a highly competitive market. Cosentyx is a key drug for Novartis, as it is part of the company’s plan to replace lost sales from ...

Secukinumab is under clinical development by Novartis and currently in Phase II for Unspecified Dermatological Disorders.

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Medically reviewed by Brendan Camp, MD Hidradenitis suppurativa (HS) is a chronic (long-term) condition that causes painful ...

Medically reviewed by Susan Bard, MD Psoriasis is a skin condition that causes skin to appear scaly and inflamed. It occurs ...

You may try options like adalimumab (Humira Pen), certolizumab pegol (Cimzia), etanercept (Enbrel), golimumab (Simponi), and secukinumab (Cosentyx). You can get these as an injection, done by ...

Objective To evaluate the effectiveness and safety of secukinumab in patients with a mucosal and articular Behçet’s phenotype resistant to conventional and biologic treatment. Methods A multicentre ...

Rystiggo (rozanolixizumab-noli) is a prescription drug that’s used to treat myasthenia gravis. This drug can interact with certain other medications. For example, Rystiggo can interact with ...

Actemra (tocilizumab) is a prescription drug that’s used to treat certain inflammatory conditions. This drug can interact with some other medications. For example, Actemra can interact with ...

Scalp psoriasis is a common skin disorder. It may look different on different skin tones. If you're light- to medium-skinned, it often shows up as raised, reddish, or salmon-colored patches with ...

Many people live for years with hidradenitis suppurativa before getting an accurate diagnosis, sometimes believing that they have acne (pimples). But HS is not acne, and it can get worse without ...